TGTPG GP A, LLC
Institutional investor · Portfolio as of Q2 2026
Top Holdings82 positions
LIFESTANCE HEALTH GROUP INC | 111.7M | $1.2B | 23.9% | — | — | — | Decreased 0 |
SPACE EXPLORATION TECHN CORP | 4.3M | $734.7M | 14.7% | — | — | — | New 98 |
JACKSON FINANCIAL INC | 4.7M | $482.8M | 9.7% | — | — | — | Unchanged 0 |
LIFE TIME GROUP HOLDINGS INC | 7.9M | $322.4M | 6.4% | — | — | — | Decreased 0 |
SIONNA THERAPEUTICS INC | 6.5M | $285.7M | 5.7% | — | — | — | Unchanged 0 |
BETA TECHNOLOGIES INC | 16.4M | $274.6M | 5.5% | — | — | — | Unchanged 0 |
AMNEAL PHARMACEUTICALS INC | 12.3M | $213.4M | 4.3% | — | — | — | Unchanged 0 |
INVITATION HOMES INC | 4.1M | $124.3M | 2.5% | — | — | — | New 78 |
NGL ENERGY PARTNERS LP | 5.8M | $92.1M | 1.8% | — | — | — | Decreased 0 |
BICARA THERAPEUTICS INC | 3M | $89.4M | 1.8% | — | — | — | Unchanged 0 |
BRUKER CORP | 175,500 | $78.3M | 1.6% | — | — | — | Increased 51 |
CERIBELL INC | 3.8M | $73.2M | 1.5% | — | — | — | Decreased 0 |
| 56.6M | $71.2M | 1.4% | — | — | — | Unchanged 0 | |
ODYSSEY THERAPEUTICS INC | 3.7M | $69M | 1.4% | — | — | — | New 68 |
ACHIEVE LIFE SCIENCES INC | 6.9M | $44.9M | 0.9% | — | — | — | New 57 |
| 29.8M | $42.3M | 0.8% | — | — | — | Decreased 0 | |
| 34M | $42.1M | 0.8% | — | — | — | Unchanged 0 | |
NOVANTA INC | 611,667 | $41.7M | 0.8% | — | — | — | Decreased 0 |
NEXTERA ENERGY INC | 825,000 | $39.3M | 0.8% | — | — | — | Increased 55 |
ALLOGENE THERAPEUTICS INC | 18.7M | $38.9M | 0.8% | — | — | — | Unchanged 0 |
TPG GP A, LLC manages $5B across 82 positions as of Q2 2026. Top holdings: LFST (23.9%), SPCX (14.7%), JXN (9.7%). Fund DNA: Momentum Trader.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR